These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3177212)

  • 1. Discriminatory pricing and packaging.
    Am Pharm; 1988 Sep; NS28(9):5-6. PubMed ID: 3177212
    [No Abstract]   [Full Text] [Related]  

  • 2. Activists dialog about pricing.
    AIDS Patient Care STDS; 1999 Apr; 13(4):247. PubMed ID: 10351896
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical costs and the drug industry.
    Schwartz H
    Wall St J Midwest Ed; 1980 Apr; 60(132):22. PubMed ID: 10245744
    [No Abstract]   [Full Text] [Related]  

  • 4. A dose of higher costs. With drug manufacturers being hit with new fees from distributors, providers and GPOs face new pricing pressures.
    Becker C
    Mod Healthc; 2004 Sep; 34(36):4-5, 10-1, 1. PubMed ID: 15458169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug costs can be defended.
    Lee AM
    Med Mark Media; 1982 Mar; 17(3):36, 38, 40 passim. PubMed ID: 10309584
    [No Abstract]   [Full Text] [Related]  

  • 6. [Unit dose packaging for Canadian hospital pharmacies--the present status].
    Best JN; Digby WR
    Can Hosp; 1968 Oct; 45(10):83-5 passim. PubMed ID: 5687313
    [No Abstract]   [Full Text] [Related]  

  • 7. View from the Nation's Capital.
    Freishtat HW
    J Clin Psychopharmacol; 1985 Apr; 5(2):117-9. PubMed ID: 3988970
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmaceutical aspect of the cost of drugs].
    Mockle JA
    Laval Med; 1968 Jun; 39(6):477-87. PubMed ID: 5679193
    [No Abstract]   [Full Text] [Related]  

  • 9. What does R&D really cost?
    Huff B
    GMHC Treat Issues; 2001; 15(7-8):1-7. PubMed ID: 11548507
    [No Abstract]   [Full Text] [Related]  

  • 10. Rising costs hold up drug discovery.
    Miller HI
    Nature; 1998 Oct; 395(6705):835. PubMed ID: 9804407
    [No Abstract]   [Full Text] [Related]  

  • 11. Pricing pain: relief in sight on drug costs?
    J Am Health Policy; 1992; 2(6):28-31. PubMed ID: 10122415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who pays what in drug development.
    Love J
    Nature; 1999 Jan; 397(6716):202. PubMed ID: 9930689
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug approval and pharmaceutical pricing.
    Kozma CM
    Manag Care Interface; 2002 Feb; 15(2):65-6. PubMed ID: 11875964
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs firms inflate research costs, watchdog says.
    Knight J
    Nature; 2001 Aug; 412(6847):571. PubMed ID: 11493879
    [No Abstract]   [Full Text] [Related]  

  • 16. New estimates of drug development costs.
    Frank RG
    J Health Econ; 2003 Mar; 22(2):325-30. PubMed ID: 12606149
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug prices. In search of a fix.
    Bell H
    Minn Med; 2001 Jan; 84(1):24-8, 30-1. PubMed ID: 11202523
    [No Abstract]   [Full Text] [Related]  

  • 18. [Programming of production in relation to that of sales and supplies. II].
    Bellentani L
    Boll Chim Farm; 1970 May; 109(5):283-305 contd. PubMed ID: 5454983
    [No Abstract]   [Full Text] [Related]  

  • 19. Michigan lab axed as Pfizer cuts costs.
    Wadman M
    Nature; 2007 Feb; 445(7127):466-7. PubMed ID: 17268437
    [No Abstract]   [Full Text] [Related]  

  • 20. Soaring drug prices send experts scrambling for a fix.
    Singer E
    Nat Med; 2004 Sep; 10(9):884. PubMed ID: 15340400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.